Pfizer CEO Bourla sold €4.6m shares on day of vaccine trial news       

Pfizer chief executive Albert Bourla sold $5.5m (€4.6m) of company shares on Monday, the day the drugmaker said its Covid-19 vaccine was 90% effective based on interim trial results, a regulatory filing showed. File Picture: AP

Pfizer chief executive Albert Bourla sold $5.5m (€4.6m) of company shares on Monday, the day the drugmaker said its Covid-19 vaccine was 90% effective based on interim trial results, a regulatory filing showed.

Mr Bourla authorised the sale of the shares on August 19, provided the stock was at least at a certain price, as part of a predetermined plan, the company said.